ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 183 filers reported holding ARCUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $474 | – | 26 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $29,404,284 | 19.15% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,864,970 | 6.40% |
| Octagon Capital Advisors LP | 2,172,000 | $39,617,280 | 5.70% |
| Boxer Capital, LLC | 1,432,200 | $26,123 | 1.28% |
| PFM Health Sciences, LP | 1,559,947 | $28,453,433 | 1.26% |
| SECTORAL ASSET MANAGEMENT INC | 293,646 | $5,356,103 | 1.03% |
| DAFNA Capital Management LLC | 175,217 | $3,195,958 | 0.96% |
| Ikarian Capital, LLC | 230,000 | $4,195,200 | 0.95% |
| Tejara Capital Ltd | 50,000 | $912,000 | 0.47% |
| Capital Impact Advisors, LLC | 20,501 | $373,938 | 0.46% |